cidofovir


EMA6



General information:


Withdrawn ID: EMA6
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): J05AB12
Molecular Formula: C8H14N3O6P
Molweight: 279.187



Withdrawal information:


Withdrawn due to drug safety reasons:No



Side-effects:

Total reported cases (submitted by medical professionals) with cidofovir as primary suspect: 165


Reported final outcomes:
Hospitalization (initial or prolonged): 42
Death: 39
Disability: 9
Life-Threatening condition: 2
Intervention required to prevent permanent impairment/damage: 1


Reported side-effects:

Side-effect Case number
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION25
Off label use20
DRUG INEFFECTIVE19
NEPHROPATHY TOXIC9
RENAL FAILURE8
NEUTROPENIA8
HYPOTONY OF EYE8
Complications of transplanted kidney8
BLOOD CREATININE INCREASED8
RENAL IMPAIRMENT7
RENAL TUBULAR DISORDER6
PYREXIA6
Acute kidney injury6
UVEITIS4
RETINOPATHY4
RENAL TUBULAR NECROSIS4
RENAL FAILURE ACUTE4
IRITIS4
IRIS ADHESIONS4
Drug resistance4
CATARACT SUBCAPSULAR4
Viral load increased3
Treatment failure3
Transplant rejection3
SQUAMOUS CELL CARCINOMA3
RASH3
PAPILLOEDEMA3
IRIDOCYCLITIS3
INTRAOCULAR PRESSURE DECREASED3
HYPOTONIA3
HAEMODIALYSIS3
DIARRHOEA3
CONFUSIONAL STATE3
Condition aggravated3
Chronic kidney disease3
WHITE BLOOD CELL COUNT DECREASED2
VOMITING2
Viral mutation identified2
Venoocclusive liver disease2
SOMNOLENCE2
Respiratory failure2
Renal tubular acidosis2
Pupil fixed2
PULMONARY OEDEMA2
PULMONARY HYPERTENSION2
Pseudomonal sepsis2
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY2
Product use issue2
Product use in unapproved indication2
Pelvic pain2
Pathogen resistance2
PANCYTOPENIA2
Neoplasm progression2
NAUSEA2
Multiple-drug resistance2
Metabolic acidosis2
MEDICATION ERROR2
Hypotension2
HYPOMAGNESAEMIA2
Hydronephrosis2
HUMAN HERPESVIRUS 6 INFECTION2
HEADACHE2
FANCONI SYNDROME ACQUIRED2
DIALYSIS2
CHOROIDAL EFFUSION2
BLOOD UREA INCREASED2
BLOOD ALKALINE PHOSPHATASE INCREASED2
BLINDNESS2
VISUAL DISTURBANCE1
VAGINAL EXFOLIATION1
URINARY INCONTINENCE1
Unevaluable event1
Tubulointerstitial nephritis1
Transplant dysfunction1
Tracheal cancer1
Toxicity to various agents1
THERAPEUTIC RESPONSE DECREASED1
Tachypnoea1
SUBDURAL HAEMORRHAGE1
SPEECH DISORDER1
SLEEP DISORDER1
SKIN ULCER1
Skin lesion1
SKIN INFECTION1
Septic shock1
Seizure1
RESPIRATORY PAPILLOMA1
RESPIRATORY DEPRESSION1
Respiratory arrest1
RENAL TUBULAR ATROPHY1
Renal transplant failure1
RENAL INTERSTITIAL FIBROSIS1
Renal injury1
RENAL DISORDER1
RECTAL PROLAPSE1
Pseudomonas infection1
PROTEINURIA1
Primary effusion lymphoma1
Pregnancy1
POST PROCEDURAL COMPLICATION1
Polyomavirus-associated nephropathy1
Pneumonitis1
Pneumonia cytomegaloviral1
Pneumonia1
PHOTOSENSITIVITY REACTION1
PERICARDIAL EFFUSION1
PANCREATITIS1
Palmar-plantar erythrodysaesthesia syndrome1
PAIN1
Oxygen saturation decreased1
OVERDOSE1
Organising pneumonia1
Nervous system disorder1
MYELOID LEUKAEMIA1
MYELODYSPLASTIC SYNDROME1
MENTAL STATUS CHANGES1
Malignant transformation1
Malaise1
LUNG DISORDER1
LOCKED-IN SYNDROME1
LEUKOPENIA1
Laryngeal squamous cell carcinoma1
LARYNGEAL DYSPLASIA1
Kidney transplant rejection1
Infection1
Incorrect route of drug administration1
INCORRECT DRUG ADMINISTRATION RATE1
Immunosuppression1
ILL-DEFINED DISORDER1
Ileus1
IDIOPATHIC THROMBOCYTOPENIC PURPURA1
Hypoxia1
HYPOKALAEMIA1
Hyperglycaemia1
Hepatic failure1
HEMIPARESIS1
HALLUCINATION1
Haemoptysis1
GLYCOSURIA1
Glottis carcinoma1
GLOMERULOSCLEROSIS1
Glomerular filtration rate decreased1
GLIOMA1
Genotype drug resistance test positive1
GAZE PALSY1
GASTROINTESTINAL INFLAMMATION1
GASTROINTESTINAL HAEMORRHAGE1
Gastrointestinal disorder1
GAMMA-GLUTAMYLTRANSFERASE INCREASED1
GAIT DISTURBANCE1
Fanconi syndrome1
EXFOLIATIVE RASH1
End stage renal disease1
Encephalopathy1
Encephalitis viral1
Encephalitis cytomegalovirus1
ELECTROENCEPHALOGRAM ABNORMAL1
Dyspnoea1
Dysphagia1
DRUG TOXICITY1
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS1
Drug prescribing error1
Drug intolerance1
Drug interaction1
Drug administration error1
DIZZINESS1
DISEASE RECURRENCE1
Disease progression1
DERMATITIS BULLOUS1
Cytomegalovirus viraemia1
Cytomegalovirus infection1
Cytomegalovirus chorioretinitis1
CONVULSION1
COGNITIVE DISORDER1
CILIARY BODY DEGENERATION1
Choroidal detachment1
CHEILITIS1
Cells in urine1
CD4 LYMPHOCYTES DECREASED1
CARDIAC DISORDER1
Cardiac arrest1
BODY TEMPERATURE INCREASED1
Blood electrolytes abnormal1
Blood bilirubin increased1
BLISTER1
BLINDNESS TRANSIENT1
BLINDNESS CORTICAL1
Bladder pain1
Bladder irritation1
BLADDER DISORDER1
BK virus infection1
ASTHENIA1
Aphonia1
ANURIA1
AGRANULOCYTOSIS1
Adenovirus infection1
Adenoviral haemorrhagic cystitis1
ACUTE HEPATIC FAILURE1
Acinetobacter infection1
ACCIDENTAL OVERDOSE1
Accidental exposure to product1
ABNORMAL BEHAVIOUR1
ABDOMINAL PAIN1





Toxicity information:

Toxicity type: N/A



External links:

ChEBML: CHEMBL152
DrugBank: DB00369